Can Fite Biofarma Ltd (CANF)
2.04
-0.03
(-1.45%)
USD |
NYAM |
May 01, 10:14
Can Fite Biofarma Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2013 | 13.22M |
| September 30, 2013 | 7.321M |
| June 30, 2013 | 7.162M |
| March 31, 2013 | 8.038M |
| December 31, 2012 | 1.499M |
| Date | Value |
|---|---|
| September 30, 2012 | 5.987M |
| June 30, 2012 | 6.000M |
| March 31, 2012 | 4.612M |
| December 31, 2011 | 4.644M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -- |
| BioLine Rx Ltd | 15.06M |
| XTL Biopharmaceuticals Ltd | -- |
| BiomX Inc | 2.899M |